Objective: the study was conducted to verify the association of hyperuricemia with lipid profile in a group of Assamese people so as to take necessary precautions from developing future cardiovascular disease (CVD).
It was Alfred Baring Garrod who first showed that subjects with gout had high concentrations of uric acid in their blood and demonstrated that their serum could crystallize on a thread previously dipped in acetic acid 1 . Hyperuricemia is a metabolic consequence originating with a wide range of etiology concerned with production and excretion of uric acid and also as a combination of both. By definition, hyperuricemia is the increase in urate concentration >420μmol/ L (7.0 mg / dl) in blood 2 . It was since 1950s when cardiovascular diseases such as stroke or ischemic heart disease was thought to be associated with serum uric acid and has been confirmed by numerous epidemiological studies conducted after that [3] [4] [5] [6] [7] [8] [9] . Elevated serum uric acid levels have been linked to hypertension, hyperinsulinemia, reduced physical activity, increased body mass index (BMI), increased alcohol consumption and decreased HDL cholesterol 6, [10] [11] [12] [13] . Hyperuricemia is said to be a mediator of proinflammatory endocrine imbalance in the adipose tissue which may be one of the factors for dyslipidemia and the inflammatory process leading to atherogensis 14 . The association of uric acid with almost all risk factors for CVD has made it very difficult to determine whether uric acid has a causal role in these conditions or whether it is simply a marker for individuals at increased risk.
Although there are several studies showing the association of lipid profile namely serum total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL) and low density lipoprotein (LDL) and serum uric acid level, there are very few studies showing this association from India and there are no such studies from North east India. As hyperuricemia is often associated with dyslipidemia which in turn is associated with CVD, indentifying hyperuricemic subjects and treating the condition can prevent CVD in such hyperuricemic subjects. With this background the present study was conducted to estimate the lipid profile in 
Selection of cases
Patient group: A group of sixty (60) patients with asymptomatic hyperuricemia / Gout in the age group of 20 -60 of either sex were selected for the study. The selected patients had no history of any cardiovascular events and were not on lipid lowering drugs. Out of the 60 patients considered for the study 27 were recently diagnosed to be diabetic (less than six month) and are either on oral hypoglycemic or on diet restriction and none were on Insulin. These recently diagnosed diabetics were considered because various studies have shown that uric acid is a predictor of diabetes but diabetes does not lead to hyperuricemia 15, [16] [17] [18] [19] . Those who had a history of diabetes for more than six months were excluded from the study. Alcoholics and subjects with renal disorders, hepatic disorders and those on drugs that may affect uric acid levels were excluded from the study.
Controls: This group consists of normal healthy individual selected randomly among people from different sectors of the society and belonging to diverse occupation and socioeconomic status. Among the subjects selected, healthy individuals, of either sex and within the age group of 20 and 60 years were included as normal controls.
A proper smoking and alcoholic history were taken from the subjects of the study. Blood pressure (BP) was measured three times consecutively on the right arm with a standard sphygmomanometer, the subject being in a sitting position after at least 30 minutes of rest 20 .
Test included
• Fasting blood sugar • Serum creatinine.
• Blood urea • Serum uric acid.
Procedure
A proper 12 hours fasting sample were used for estimation of serum total cholesterol (TC), triglyceride (TG), High Density Lipoprotein cholesterol (HDL), Low Density Lipoprotein cholesterol (LDL), fasting blood sugar and serum uric acid. For rest of the test non fasting sample were used. All the tests done in the present study were performed using Vitros 350 dry chemistry analyser manufactured by Ortho Clinical Diagnostics of Jhonson & Jhonson, USA. LDL Cholesterol was calculated using Friedewald's formula.
Statistical analysis
The statistical analysis was done manually. The results of the study were expressed as mean ± standard deviation (SD). The statistical significance of difference between the various groups was determined by using the student's ttest, and a p value of < 0.005 is considered test, and a p value of < 0.005 is considered significant.
RESULTS AND OBSERVATIONS
The study was conducted with 60 subjects as controls with 41 male and 19 female. While in the Patient group out of 60 hyperuricemic patients 45 were male and 15 were females. Table 1 and Figure I shows the statistical value for serum uric acid in both the Control and the patient group. The mean level of serum uric acid in the control and the patient group are 4.6 ± 0.74 mg/dl and 8.0 ± 0.65 mg/dl respectively (p < 0.005). Figure 1 shows the bar-diagram depicting the mean values of the two groups. Table 2 shows that there is no significant correlation of serum urea and creatinine among the patient group and the control group which signifies a normal renal profile in both the 
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Mean uric acid in patient and control groups control and the patient group. Table 2 represents the mean ± SD for serum creatinine and serum urea among the patients and the control subjects. The study reveals a definite relation between hyperuricemia and dyslipidemia. The study shows a significant correlation (p < 0.005) in the levels of TC, TG, HDL and LDL between hyperuricemic patient group and normal healthy control group. Though TC is only slightly raised above the upper normal permitted level according to National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guideline in the patient group, there is a significant correlation (p < 0.005) between the patient and the control groups, the mean ± SD being 203 ± 22.8 and 140.6 ± 12 respectively. Table 3 shows the mean ± SD values for TC, TG, HDL and LDL for both the patient and control group. 
DISCUSSION
The study was conducted to verify whether hyperuricemia without a known cardiovascular disease is associated with dyslipidemia, so that identifying and treating such person can prevent development of CVD. Therefore only hyperuricemic people without a known CVD and who are not diabetic for more than six months were considered for the study. Hyperuricemia is a metabolic consequence originating with a wide range of etiology concerned with increase production or decrease excretion of uric acid and also as a combination of both 1 . The study shows a normal renal profile in the patient and the control group, which signifies that the hyperuricemia under study is not due to decrease excretion of uric acid. There are enough evidence that hyperuricemia has been linked with cardiovascular diseases [3] [4] [5] [6] [7] [8] [9] . Hyperuricemia predispose to the development of hypertension and is also thought to result in increase oxidative stress and generation of free radicals, which eventually can be the nidus of future cardiovascular disease 14, 21 . Animal model study have proved that uric acid causes dramatic increase in the expression and release of MCP-1, infiltration of macrophages and expression of proinflammatory cytokine TNF-α in the vascular smooth muscles, and thus can eventually lead to smooth muscles, and thus can eventually lead to atherosclerosis 14 . This is not the only cause of increase risk of CVD in hyperuricemic patients. One of the earliest studies documenting hypertriglyceridemia in hyperuricemic patients is shown by Bendek and later various studies have proved this association 22 . Various studies have shown an inverse relationship between HDL and uric acid. The negative correlation of HDL in hyperuricemia resulted in decrease in good cholesterol (HDL) and consequently and increase in atherosclerosis and eventually predisposes to CVD. LDL cholesterol is always considered to be bad cholesterol and increase in LDL results in atherosclerosis which leads to various cardiovascular events ranging from angina to myocardial infarction 10, 11, [23] [24] [25] . According to the latest ATP III guideline the optimal level of TC, TG, HDL and LDL are < 200 mg/dl, < 150 mg/dl, > 40 mg/dl and < 100 mg/dl respectively 26 . Madhumita et al. has shown from a study conducted on 1485 Assamese subjects that an average healthy urban Assamese population has a TC, TG, HDL and LDL value of 170 mg/dl, 110 mg/dl, 40 mg/dl and 103 mg/dl respectively 27 . Considering the ATP III criteria as well as the values provided by study of Madhumita et al., the hyperuricemic cases in the present study are associated with dyslipidemia. The study proves a significant positive correlation (p < 0.005) between hyperuricemia and TC, TG and LDL and a significant negative correlation (p < 0.005) between hyperuricemia and HDL. Therefore, it is inferred that hyperuricemia is associated with dyslipidemia in Assamese population as is for other ethnic groups and races proved by various studies, and these hyperuricemic are at a high risk for developing CVD.
Metabolic syndrome is associated with insulin resistance and therefore diabetes and also dyslipidemia, and in turn hyperinsulinemia also dyslipidemia, and in turn hyperinsulinemia is associated with hyperuricemia 11 . Our study includes 27 diabetic in whom status of insulin resistance is not taken into accounts; further BMI is not calculated in any of the study population which we consider as the demerits of the study. Consideration of the BMI and taking an account of the metabolic syndrome criteria in the study population could give a more clear understanding of the association of hyperuricemia and dyslipidemia. Also the study included only 60 prospective hyperuricemic subjects and a study conducted in a large population is expected to give a better association between uric acid and lipid profile.
CONCLUSION
The present study proves that hyperuricemia is often associated with dyslipidemia, which can lead to a possible cardiovascular event. So prevention of hyperuricemia and associated dyslipidemia can reduce the incidence of CVD in such subjects. A large scale study taking into account the metabolic syndrome, diabetes, BMI, life style etc. are however needed to avail a better understanding of this association.
